Increasing resistance of acinetobacter species to imipenem in United States hospitals, 1999-2006

Infection Control and Hospital Epidemiology

Volumn 31, Issue 2, 2010, Pages 196-197

  Hoffmann, Marc S ^a   Eber, Michael R ^b   Laxminarayan, Ramanan ^b,c,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Center for Disease Dynamics Economics and Policy   (United States)

^c PRINCETON UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; IMIPENEM;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHI SQUARE TEST; DISEASE SURVEILLANCE; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION CONTROL; NONHUMAN; SAMPLE SIZE; UNITED STATES;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HOSPITALS; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; UNITED STATES;

EID: 75949104744     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/650379     Document Type: Article

References (10)

1. Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005;41:848-854.
2. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med 2008;358:1271-1281.
3. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008;46:1254-1263.
4. Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29:996-1011.
5. Carey RB, Banerjee S, Srinivasan A. Multidrug-resistant Acinetobacter infections, 1995-2004. In: Program and abstracts of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 27-30, 2006; San Francisco, CA.
6. Styers D, Sheehan DJ, Hogan P, Sahm DF. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 2006;5:2.
7. Sahm DF, Marsilio MK, Piazza G. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with The Surveillance Network Database - USA. Clin Infect Dis 1999;29:259-263.
8. Hindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis 2007;44:867-873.
9. Lockhart SR, Abramson MA, Beekmann SE, et al. Antimicrobial resistance among gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol 2007;45:3352-3359.
10. Kulah C, Aktas E, Comert F, Ozlu N, Akyar I, Ankarali H. Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan Walk Away, Vitek 2); high error rates with Microscan Walk Away. BMC Infect Dis 2009;9:30.